Therapeutic Asset Ratings
193 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pyrotinib
Endometrial Cancer
Hutchmed
P1/2
CC
(46)
rc48-adc
Endometrial Cancer
Hutchmed
P1/2
CC
(46)
Ribociclib
Endometrial Cancer
Avenzo Therapeutics, Inc.
P1/2
CC
(46)
Tislelizumab
Endometrial Cancer
Hutchmed
P1/2
CC
(46)
Zoladex
Endometrial Cancer
Avenzo Therapeutics, Inc.
P1/2
CC
(46)
gsk2110183
Endometrial Cancer
Laekna Limited
P1/2
CC
(44)
Vudalimab
Endometrial Cancer
Xencor, Inc.
P2
CC
(42)
177lu-betabart
Endometrial Cancer
Radiopharm Theranostics, Ltd
P1/2
CC
(41)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Endometrial Cancer
AstraZeneca
P1/2
CC
(41)
Adebrelimab
Endometrial Cancer
Hutchmed
P1/2
CC
(41)
Alnodesertib
Endometrial Cancer
Artios Pharma Ltd
P1/2
CC
(41)
Amxt1501
Endometrial Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(41)
Avzo-021
Endometrial Cancer
Avenzo Therapeutics, Inc.
P1/2
CC
(41)
azd5305
Endometrial Cancer
AstraZeneca
P1/2
CC
(41)
Benmelstobart
Endometrial Cancer
Beijing Tide Pharmaceutical Co., Ltd
P1/2
CC
(41)
Camizestrant
Endometrial Cancer
AstraZeneca
P1/2
CC
(41)
Eflornithine
Endometrial Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(41)
eik1005
Endometrial Cancer
Eikon Therapeutics
P1/2
CC
(41)
Enzalutamide
Endometrial Cancer
Cancer Research UK
P1/2
CC
(41)
Etx-19477
Endometrial Cancer
858 Therapeutics, Inc.
P1/2
CC
(41)
Fianlimab
Endometrial Cancer
Regeneron Pharmaceuticals
P1/2
CC
(41)
Fruquintinib
Endometrial Cancer
Hutchmed
P1/2
CC
(41)
Gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV4-31*01 (89.9%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 (85.3%)-IGKJ2*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1,glycoform alfa
Endometrial Cancer
Cancer Research UK
P1/2
CC
(41)
gen1107
Endometrial Cancer
Genmab
P1/2
CC
(41)
gsk4418959
Endometrial Cancer
GlaxoSmithKline
P1/2
CC
(41)
Showing 76 to 100 of 193 assets
Previous
Page 4 of 8
Next
